![PDF] Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus | Semantic Scholar PDF] Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/872ed41d21dd6b4abf69403e226b553da329f33b/5-Figure1-1.png)
PDF] Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus | Semantic Scholar
![A, Anti-HBs (GMC) at 2 and 4 weeks after a recombinant vaccine booster... | Download Scientific Diagram A, Anti-HBs (GMC) at 2 and 4 weeks after a recombinant vaccine booster... | Download Scientific Diagram](https://www.researchgate.net/publication/6202582/figure/fig2/AS:280082154311690@1443788197476/A-Anti-HBs-GMC-at-2-and-4-weeks-after-a-recombinant-vaccine-booster-dose-among.png)
A, Anti-HBs (GMC) at 2 and 4 weeks after a recombinant vaccine booster... | Download Scientific Diagram
![Therapeutic vaccination for treatment of chronic hepatitis B - Cargill - 2021 - Clinical & Experimental Immunology - Wiley Online Library Therapeutic vaccination for treatment of chronic hepatitis B - Cargill - 2021 - Clinical & Experimental Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e776877b-8d46-4446-b9b8-0c36ef24eb60/cei13614-toc-0001-m.jpg?trick=1695013761632)
Therapeutic vaccination for treatment of chronic hepatitis B - Cargill - 2021 - Clinical & Experimental Immunology - Wiley Online Library
![Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity: Molecular Therapy - Methods & Clinical Development Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/11f54e1c-2994-433c-b95d-0bb9e6443896/fx1_lrg.jpg)
Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity: Molecular Therapy - Methods & Clinical Development
![Figure 2: Algorithm for HBV Screening and Vaccination in Patients With HIV - Prevention and Management of Hepatitis B Virus Infection in Adults With HIV - NCBI Bookshelf Figure 2: Algorithm for HBV Screening and Vaccination in Patients With HIV - Prevention and Management of Hepatitis B Virus Infection in Adults With HIV - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK584516/bin/nycghepb-Image002.jpg)
Figure 2: Algorithm for HBV Screening and Vaccination in Patients With HIV - Prevention and Management of Hepatitis B Virus Infection in Adults With HIV - NCBI Bookshelf
![Complementary Presence of HBV Humoral and T-cell Response Provides Protective Immunity after Neonatal Immunization Complementary Presence of HBV Humoral and T-cell Response Provides Protective Immunity after Neonatal Immunization](https://publinestorage.blob.core.windows.net/1f06501d-7a13-4dc3-be46-228c22b626b9/jcth-10-660-g003.jpg)
Complementary Presence of HBV Humoral and T-cell Response Provides Protective Immunity after Neonatal Immunization
![Immune response to different types of hepatitis B vaccine booster doses 2–32 years after the primary immunization schedule and its influencing factors - ScienceDirect Immune response to different types of hepatitis B vaccine booster doses 2–32 years after the primary immunization schedule and its influencing factors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1201971220300503-gr1.jpg)
Immune response to different types of hepatitis B vaccine booster doses 2–32 years after the primary immunization schedule and its influencing factors - ScienceDirect
![Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices | MMWR Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices | MMWR](https://www.cdc.gov/mmwr/volumes/67/rr/figures/rr6701a1-F2.gif)
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices | MMWR
![Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination | BMC Infectious Diseases | Full Text Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination | BMC Infectious Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-019-4134-9/MediaObjects/12879_2019_4134_Fig3_HTML.png)
Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination | BMC Infectious Diseases | Full Text
![Frontiers | Immune Status Against Hepatitis B in Patients After Allogeneic Hematopoietic Cell Transplantation—Factors Affecting Early and Long-Lasting Maintenance of Protective Anti-HBs Titers Frontiers | Immune Status Against Hepatitis B in Patients After Allogeneic Hematopoietic Cell Transplantation—Factors Affecting Early and Long-Lasting Maintenance of Protective Anti-HBs Titers](https://www.frontiersin.org/files/Articles/586523/fimmu-11-586523-HTML-r1/image_m/fimmu-11-586523-g001.jpg)
Frontiers | Immune Status Against Hepatitis B in Patients After Allogeneic Hematopoietic Cell Transplantation—Factors Affecting Early and Long-Lasting Maintenance of Protective Anti-HBs Titers
![Vaccines | Free Full-Text | Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus Vaccines | Free Full-Text | Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus](https://pub.mdpi-res.com/vaccines/vaccines-09-00323/article_deploy/html/images/vaccines-09-00323-g001-550.jpg?1628018080)
Vaccines | Free Full-Text | Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus
![Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 | MMWR Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 | MMWR](https://www.cdc.gov/mmwr/volumes/72/rr/social-media/rr7201a1_HepatitisB_IMAGE_10Mar2023_1200x675-v2-medium.jpg?_=10974)